Pharmacological force of Xeloda

Xeloda (capecitabine) is a cytostatic. Capecitabine is a derivative of fluoropyrimidine carbamate, which was developed as an uttered cytostatic, activated in tumor web and rendered it not a choosy cytotoxic effect. In vitro xeloda generic does not contain a cytotoxic effect. Despite that, in vivo it is converted into a cytotoxic aggravate - fluorouracil (5-FU), which undergoes further metabolism. The formation of 5-FU occurs in the tumor pack under the sway of tumor angiogenic factors - thymidine (dTdFazy), which as follows minimizes systemic exposure to 5-FU on nutritious tissues. As a emerge of selective activation of the content of 5-FU in the tumor significantly it is higher than the levels in flourishing tissues.

To den the selective action of xeloda in tumor was conducted pharmacokinetic experiment comparing capecitabine concentration in the tumor, thriving tissue and plasma of cancer patients. Following oral management of cost of xeloda (1255 mg/m2 amount twice a day exchange for 5-7 days in advance surgery), a concentration of 5-FU in unmixed tumor were significantly higher than in circumjacent healthy chain (geometric norm correlation 2.5) and plasma (the ratio geometric backing 14). The liveliness of thymidine phosphorylase in the primeval tumor is 4 times higher than in nutritious tissue. In vulnerable tumors, such as bosom, relish, and rectum, cervical and ovarian cancer, with a lot more thymidine is able to metamorphose 5'-DFUR (5'-deoxy-5-fluorouridine) to 5-FU than in thriving tissues.

Profuse people secure capecitabine because they know that both fit and tumor cells metabolize 5-FU to 5-fluoro-2-deoxyuridine monophosphate (FdUMF) and 5-fluorouridine triphosphate (FUTF). These metabolites producer damage to cells with the aid two disparate mechanisms. Essential, folate and FdUMF cofactor N5-10-methylenetetrahydrofolate bind to thymidylate synthase in the development of covalently forced tertiary sector. This binding inhibits the disposition of thymidylate from uracil. Thymidylate is a resultant vanguard of thymidine triphosphate, which in turn is vital in place of DNA compound, so the fall short of of this stuff can be ahead of to check of room dividing. Secondly, in the coalescence of RNA transcription enzyme gist may incorrectly include a FUTF as an alternative of uridine triphosphate (UTP). This metabolic "wickedness" violates the processing of RNA and protein synthesis.

Antitumor energy of capecitabine generic was evaluated in patients with breast cancer originate IV. This category of patients who already received a ponderous treatment, has been refractory to before-mentioned treatment with paclitaxel conducted. In addition, 41% of patients were ungovernable and 26% lacking the tenor of earlier group therapy with anthracyclines, 82% of patients had already received 5-FU. That is why scads patients with cancer gain capecitabine. The primary endpoint of the reading was objective tumor shrinkage (where they can be resolved). Remission was considered a reduction in the diameter of the tumor not less than 50% allowing for regarding at least 1 month. xeloda 500mg was administered at a daily quantity of 2510 mg/m2 as a service to 2 weeks, then did a week break and re-administered the soporific in the profile of a three-week cycles.